Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Krastsvetmet is a Russian precious-metals refining and manufacturing company headquartered in Krasnoyarsk. The company is one of the country’s largest producers of refined gold, silver, and platinum-group metals, and also manufactures industrial products, catalytic systems, jewelry, and specialty precious-metal compounds. It provides refining, analytical, logistics, and industrial engineering services and operates an R&D park focused on precious-metal technologies. Although it supplies some medical and pharmaceutical platinum compounds such as cisplatin, carboplatin, and oxaliplatin intermediates/substances, it is not primarily a life sciences or biotech company. Its core business is industrial metals processing and downstream precious-metal products rather than drug discovery or therapeutic development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Krastsvetmet.